Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study
In patients treated with metoprolol after MI, variation in metoprolol exposure determined by CYP2D6 did not impact the occurrence of cardiovascular events.
Authors
- Marianne Kristiansen Kringen (ORCID: https://orcid.org/0000-0002-4760-1693)
- Erik Øie (ORCID: https://orcid.org/0000-0002-1562-2924)
- Geir Øystein Andersen (ORCID: https://orcid.org/0000-0003-1578-6440)
- Lina Dorthea Bruun
- Espen Molden (ORCID: https://orcid.org/0000-0001-6190-2751)
- Sigrun Halvorsen (ORCID: https://orcid.org/0000-0001-7561-7644)
- C Holst Hansen (ORCID: https://orcid.org/0000-0002-7817-011X)
- Peder Langeland Myhre (ORCID: https://orcid.org/0000-0002-5871-1804)
Institutions
- Oslo University Hospital (NO)
- OsloMet – Oslo Metropolitan University (NO)
- University of Oslo (NO)
- Akershus University Hospital (NO)
- Diakonhjemmet Hospital (NO)
Publication Details
- Journal
- European Journal of Clinical Pharmacology
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1007/s00228-025-03806-w
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitetet i Oslo
- Diakonhjemmet